ABC Pharmaceuticals is a leading biopharmaceutical company focused on developing innovative treatments for various diseases, including cancer, autoimmune disorders, and infectious diseases.

ABC Pharmaceuticals

PitchBook is the leading resource for comprehensive data, research and insights spanning the global capital markets. Our unprecedented offerings are brought to life through the PitchBook Platform, a dynamic suite of products designed to help you win.

Founded in 2007, CEO John Gabbert knew that his idea for an actionable, extensive database for private equity-focused intelligence was worth pursuing. The rest is PitchBook history.

Since those early days, PitchBook has expanded its coverage areas to include the entirety of the global public and private markets. We’ve added thousands of datasets and millions of individual insights into the platform, and we’ve pioneered new features and products that surface the information our clients need. We look at every day as a new opportunity to meet and exceed our customers’ expectations through helping them make informed decisions that propel their firms forward. 

Part of Morningstar since 2016, PitchBook is headquartered in Seattle, London and Hong Kong with additional offices in New York and San Francisco.

Morningstar

Brock Mansfield

PitchBook

Private equity has been transformed over the past three decades: aggregate annual deal volumes from the 1980s until the end of the century rarely topped 1 per cent of GDP, even in the US. Over the past four years, that ratio has ranged between 2 and 5 per cent, our data suggests. 

Find more in Patrick Jenkins' opinion piece in the Financial Times 👇

🤖 Generative #AI was a runaway success in 2023, but with regulatory action and the involvement of big tech potentially affecting this specific use case, investors are also beginning to explore artificial intelligence in areas like:

🔬 #Healthtech
🖥️ Software
🤝 #B2B

With a growing list of technologies being enhanced or replaced by artificial intelligence, AI might influence your industry sooner than you think. 

Learn why AI should be considered in your team’s corporate strategy in 2024 here: https://pitchb.co/BJ8UwF

🔎 Private equity wants to attract a new kind of limited partner: the high-net-worth #investor. The industry has been deepening its foothold in products for traditional wealth management clients.

But the trend does come with potentially negative fallout, including the risk of cherry-picking, writes PitchBook's Jessica Hamlin.

🗞 Welcome to The Weekly Pitch, our LinkedIn newsletter. Every Friday, we compile the week’s top news and research from our team of industry-leading sources for info on the worlds of VC, PE and M&A. Find it here 👇

On February 29, the Seattle Kraken and the Pittsburgh Penguins will face off at Leap Year Night presented by PitchBook—and PitchBook wants to give you tickets. 

We’re giving away a total of 29 pairs of tickets with daily drawings all month long. Plus, one lucky grand prize winner will get a full VIP experience, complete with:
	
🏒 100-level seats 
🏒 A one-night stay at the Fairmont Olympic Hotel 
🏒 Dinner for two at Metropolitan Grill 
🏒 Car service to and from dinner and the game

Take a leap and try your luck! We can’t wait to see you there. 

🎟️ Enter the giveaway here ➡️ https://lnkd.in/ggSNXWeN

👏🏆 Yesterday, we celebrated some of the many outstanding PitchBook team members at our annual Panther Awards ceremony—a tradition that honors those who exemplify our values and culture every day. Congratulations to all of our winners and finalists!

Our people are our most valuable asset. With more than 1,100 award nominations submitted by our employees, we are proud to have a culture that recognizes and celebrates the success of others. 

Thank you to everyone at PitchBook for your hard work and dedication. We couldn't be prouder of our Panther Award winners and the entire team. Here's to another successful year ahead! 🎉

✨ We ended 2023 in style! Check out some highlights from our office holiday parties in London, New York, Seattle, and San Francisco. 

#LifeAtPB

🔎 Join us as our emerging tech analysts investigate Y Combinator's newest crop of CRM startups and their plans to out-innovate incumbents.

Analysts Derek Hernandez and James Ulan sit down with multiple #founders to discuss how they're building better products and their experiences helping enterprises and SMBs track customers, provide technical support and more.

💡 Reserve your spot for the webinar here: https://lnkd.in/g3__hRbD

🌏 Worldwide M&A deal value reached $3 trillion in 2023, marking it the second-weakest year in a decade. But there's some good news: other metrics imply the worst may be behind us, according to our 2023 Annual Global M&A Report, including:

💡 The total estimated M&A deal count in 2023 was 40,200—the third-highest on record. 

💡 The Federal Reserve’s pivot to interest-rate cuts raises optimism for an upcoming recovery in the deal market. 

💡 Public multiples have sprinted ahead of private multiples, setting the stage for a catch-up move.

Learn more in the report here: https://lnkd.in/gcVTM-vx

In a Wednesday vote, the Securities and Exchange Commission approved a set of sweeping rules and amendments related to special purpose acquisition companies.

The new regulations will increase disclosure requirements for SPAC sponsors in an effort to protect #investors, but industry players also believe the ruling will have a stifling effect on the already-shrunken pipeline of blank-check companies taking private firms to the public markets.

Learn more about what this means from our news team here 👇

COM:PITCHBOOK

ABC Pharmaceuticals

Financials Not Available